M
Manfred Kraus
Researcher at Merck & Co.
Publications - 18
Citations - 1027
Manfred Kraus is an academic researcher from Merck & Co.. The author has contributed to research in topics: B cell & Cellular differentiation. The author has an hindex of 12, co-authored 14 publications receiving 976 citations. Previous affiliations of Manfred Kraus include Harvard University & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Critical functions for c-Myb at three checkpoints during thymocyte development.
TL;DR: Three points at which c-Myb activity is required for normal T cell differentiation are identified: transition through the double-negative 3 stage, survival of preselection CD4+CD8+ thymocytes, and differentiation of CD4Thymocytes.
Journal ArticleDOI
Basal immunoglobulin signaling actively maintains developmental stage in immature B cells.
Lina E. Tze,Brian R. Schram,Kong-Peng Lam,Kristin A. Hogquist,Keli L. Hippen,Jiabin Liu,Susan A. Shinton,Kevin L. Otipoby,Peter R. Rodine,Amanda L. Vegoe,Manfred Kraus,Richard R. Hardy,Mark S. Schlissel,Klaus Rajewsky,Timothy W. Behrens +14 more
TL;DR: It is shown that interruption of basal IgM signaling in immature B cells, either by the inducible deletion of surface Ig via Cre-mediated excision or by incubating cells with the tyrosine kinase inhibitor herbimycin A or the phosphatidylinositol 3-kinase inhibitor wortmannin led to a striking “back-differentiation” of cells to an earlier stage in B cell development.
Journal ArticleDOI
Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors
Jannik N. Andersen,Sriram Sathyanarayanan,Alessandra Di Bacco,An Chi,Theresa Zhang,Albert H. Y. Chen,Brian Dolinski,Manfred Kraus,Brian S. Roberts,William Arthur,Rich A. Klinghoffer,Diana Gargano,Lixia Li,Igor Feldman,Bethany Lynch,John Rush,Ronald C. Hendrickson,Peter Blume-Jensen,Cloud P. Paweletz +18 more
TL;DR: A pathway-based phosphoprofiling approach to identify and quantify clinically relevant, drug-specific biomarkers for phosphatidylinositol 3-kinase (PI3K) pathway inhibitors that target AKT, phosphoinositide-dependent kinase 1 (PDK1), and PI3K–mammalian target of rapamycin (mTOR) is reported.
Journal ArticleDOI
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Igα/β
Ari Waisman,Manfred Kraus,Jane Seagal,Snigdha Ghosh,Doron Melamed,Doron Melamed,Jian Song,Jian Song,Yoshiteru Sasaki,Sabine Classen,Claudia Lutz,Frank Brombacher,Lars Nitschke,Klaus Rajewsky +13 more
TL;DR: The results suggest that the γ1 chain can exert a unique signaling function that can partially replace that of the Igα/β heterodimer in B cell maintenance and may contribute to memory B cell physiology.
Journal ArticleDOI
B Cells Are Crucial for Both Development and Maintenance of the Splenic Marginal Zone
Martijn A. Nolte,Ramon Arens,Manfred Kraus,Marinus H. J. van Oers,Georg Kraal,René A. W. van Lier,Reina E. Mebius +6 more
TL;DR: In this article, the authors demonstrate that both development and maintenance of the splenic marginal zone is highly dependent on the presence of B cells and that B cells are not only important for the development, but also for maintenance, of the marginal zone.